ArticleSports medicine (Auckland, N.Z.)2026
Vitamin B6 in Elite Athletes: Potential Implications of High Intakes.
Article in Sports medicine (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vitamin B6 plays a role in over 100 enzymatic reactions, and it is purported that athletes have higher requirements compared with the general population. Deficiency, while rare, may lead to adverse symptoms if severe or prolonged. Conversely, excessive intake may increase the risk of toxicity. This article discusses the potential implications of high vitamin B6 exposure in athletes and includes illustrative observational data on plasma pyridoxal 5'-phosphate (PLP) from routine biomarker monitoring in elite athletes. Observation-level deficiencies (< 30 nmol/L; 5.2%) and raised (> 125 nmol/L; 38.7%) PLP measurements (n = 654) in elite athletes (N = 396) participating in routine biomarker screening, alongside implications of possible intakes above athletes' requirements are discussed. Athletes' use of nutritional supplements, sports beverages, or even intravenous nutrition, which contain highly bioavailable doses of vitamin B6, are a plausible contributor to the observed high PLP concentrations. Chronic total vitamin B6 intake above 21 mg/day, particularly with low protein intake, may increase toxicity risk.
Identifiers
42730844What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.